Insider · CIK 0001197036

SACHS BRUCE I

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001197036

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+92.694 sh	$512.44	+$47.5K	15,864.501
2026-08-27	VRTXVERTEX PHARMACEUTICALS INC / MAG Gift	Director	GGift	−6,000 sh	—	—	39,000
2026-07-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+99.941 sh	$475.28	+$47.5K	15,771.807
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+2,866 sh	—	—	2,866
2026-04-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+107.345 sh	$442.50	+$47.5K	15,671.866
2026-01-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+107.088 sh	$443.56	+$47.5K	15,564.521
2025-10-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+115.766 sh	$410.31	+$47.5K	15,457.433
2025-08-06	VRTXVERTEX PHARMACEUTICALS INC / MAP Purchase	Director	PPurchase	+1,634 sh	$389.36	+$636K	41,634
2025-08-06	VRTXVERTEX PHARMACEUTICALS INC / MAP Purchase	Director	PPurchase	+3,366 sh	$389.84	+$1.31M	45,000
2025-07-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+101.206 sh	$469.34	+$47.5K	15,341.667
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+2,398 sh	—	—	2,398
2025-04-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+95.475 sh	$497.51	+$47.5K	15,240.461
2025-01-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+111.654 sh	$420.31	+$46.9K	15,144.986
2024-10-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+90.32 sh	$484.39	+$43.8K	15,033.332
2024-08-01	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+5,295 sh	$125.71	+$666K	45,295
2024-08-01	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−5,295 sh	$508.00	−$2.69M	40,000
2024-08-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,295 sh	—	—	0
2024-07-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+89.264 sh	$490.12	+$43.8K	14,943.012
2024-05-22	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+7,073 sh	$93.51	+$661K	47,073
2024-05-22	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−7,073 sh	$448.00	−$3.17M	40,000
2024-05-22	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,073 sh	—	—	0
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+3,142 sh	—	—	3,142
2024-04-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+109.49 sh	$399.58	+$43.8K	14,853.748
2024-01-12	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+101.042 sh	$432.99	+$43.8K	14,744.258
2023-11-06	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$127.54	+$1.43M	51,250
2023-11-06	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−11.3K sh	$385.00	−$4.33M	40,000
2023-11-06	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	11,250
2023-10-13	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+118.25 sh	$369.98	+$43.8K	14,643.216
2023-07-17	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$127.54	+$1.43M	51,250
2023-07-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−1,697 sh	$355.54	−$603K	49,553
2023-07-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−5,711 sh	$356.75	−$2.04M	43,842
2023-07-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−3,842 sh	$357.29	−$1.37M	40,000
2023-07-17	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	11,250
2023-07-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+124.719 sh	$350.79	+$43.8K	14,524.966
2023-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+3,481 sh	—	—	3,481
2023-04-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+131.473 sh	$332.77	+$43.8K	14,400.247
2023-04-13	VRTXVERTEX PHARMACEUTICALS INC / MAG Gift	Director	GGift	−1,210 sh	—	—	40,000
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+21.3K sh	$72.14	+$1.54M	62,510
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−2,917 sh	$325.65	−$950K	59,593
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−10.4K sh	$326.46	−$3.38M	49,236
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−8,026 sh	$327.48	−$2.63M	41,210
2023-04-12	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.3K sh	—	—	0
2023-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+1,200 sh	$72.14	+$86.6K	42,410
2023-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−1,200 sh	$325.01	−$390K	41,210
2023-01-31	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,200 sh	—	—	21,300
2023-01-13	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+146.606 sh	$298.42	+$43.8K	14,268.774
2022-10-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+147.396 sh	$296.82	+$43.8K	14,122.168
2022-07-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+151.264 sh	$289.23	+$43.8K	13,974.772
2022-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+4,462 sh	—	—	4,462
2022-04-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+151.17 sh	$289.41	+$43.8K	13,823.508

Recent filings

Accepted (ET)
Oct 194
SACHS BRUCE I0000875320-26-000276
SEC(opens sec.gov)
Aug 314
SACHS BRUCE I0000875320-26-000261
SEC(opens sec.gov)
Jul 174
SACHS BRUCE I0000875320-26-000249
SEC(opens sec.gov)
May 54
SACHS BRUCE I0000875320-26-000187
SEC(opens sec.gov)
Apr 174
SACHS BRUCE I0000875320-26-000161
SEC(opens sec.gov)
Jan 204
SACHS BRUCE I0000875320-26-000006
SEC(opens sec.gov)
Oct 174
SACHS BRUCE I0000875320-25-000226
SEC(opens sec.gov)
Aug 74
SACHS BRUCE I0000875320-25-000218
SEC(opens sec.gov)
Jul 174
SACHS BRUCE I0000875320-25-000208
SEC(opens sec.gov)
May 54
SACHS BRUCE I0000875320-25-000184
SEC(opens sec.gov)
Apr 174
SACHS BRUCE I0000875320-25-000164
SEC(opens sec.gov)
Jan 174
SACHS BRUCE I0000875320-25-000002
SEC(opens sec.gov)
Oct 174
SACHS BRUCE I0000875320-24-000216
SEC(opens sec.gov)
Aug 24
SACHS BRUCE I0000875320-24-000200
SEC(opens sec.gov)
Jul 174
SACHS BRUCE I0000875320-24-000185
SEC(opens sec.gov)
May 244
SACHS BRUCE I0000875320-24-000158
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVE

BOSTON, MA, 02210